ADDITIONAL ACR, EULAR, AND DAS28 RESPONSES AT 24 WEEKS IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO WERE NON-RESPONDERS TO COMBINED ETANERCEPT AND METHOTREXATE THERAPY AT 12 WEEKS

A. Kavanaugh , D. Chang , B. Freundlich , J. Li , S. Lin , M. Hooper Center of Innovative Therapy, La Jolla, California, Wyeth Pharmaceuticals, Collegeville, Philadelphia, Amgen Inc., Thousand Oaks, California, United StatesCitation: Ann Rheum Dis, volume 66, supplement II, year 2007, page 599Session: RA – anti-TNF therapy